| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.27 | 1e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |